These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 8918418

  • 1. The recipient origin of posttransplant lymphoproliferative disorders in pulmonary transplant patients. A report of three cases.
    Wood BL, Sabath D, Broudy VC, Raghu G.
    Cancer; 1996 Nov 15; 78(10):2223-8. PubMed ID: 8918418
    [Abstract] [Full Text] [Related]

  • 2. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML, Swinnen LJ, Plaisance KT, Schnell C, Grogan TM, Schneider BG, Southwest Oncology Group.
    Transplantation; 2003 Sep 27; 76(6):959-64. PubMed ID: 14508361
    [Abstract] [Full Text] [Related]

  • 3. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
    Gong JZ, Bayerl MG, Sandhaus LM, Sebastian S, Rehder CW, Routbort M, Lagoo AS, Szabolcs P, Chiu J, Comito M, Buckley PJ.
    Am J Surg Pathol; 2006 Mar 27; 30(3):328-36. PubMed ID: 16538052
    [Abstract] [Full Text] [Related]

  • 4. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan 27; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 5. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
    Heyny-von Haussen R, Klingel K, Riegel W, Kandolf R, Mall G.
    Am J Surg Pathol; 2006 Jul 27; 30(7):900-5. PubMed ID: 16819335
    [Abstract] [Full Text] [Related]

  • 6. Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis.
    Capello D, Berra E, Cerri M, Gaidano G.
    Minerva Med; 2004 Feb 27; 95(1):53-64. PubMed ID: 15041926
    [Abstract] [Full Text] [Related]

  • 7. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C, Giacchino F, Bergallo M, Bonello F, Bollero C, Segoloni GP, Cavallo R.
    G Ital Nefrol; 2003 Feb 27; 20(2):170-5. PubMed ID: 12746803
    [Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.
    Bakker NA, Verschuuren EA, Erasmus ME, Hepkema BG, Veeger NJ, Kallenberg CG, van der Bij W.
    Transplantation; 2007 Feb 27; 83(4):433-8. PubMed ID: 17318076
    [Abstract] [Full Text] [Related]

  • 9. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.
    Leung E, Shenton BK, Green K, Jackson G, Gould FK, Yap C, Talbot D.
    Transpl Infect Dis; 2004 Dec 27; 6(4):156-64. PubMed ID: 15762933
    [Abstract] [Full Text] [Related]

  • 10. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC, Curtis JL, Szmuszkovicz JR, Horn MV, Ford HR, Woo MS, Wang KS.
    J Pediatr Surg; 2008 Dec 27; 43(12):2174-7. PubMed ID: 19040929
    [Abstract] [Full Text] [Related]

  • 11. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M, Nosari A, Morra E, Cooperative Study Group on PTLDs.
    Haematologica; 2002 Jan 27; 87(1):67-77. PubMed ID: 11801467
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus detection in sequential biopsies from patients with a posttransplant lymphoproliferative disorder.
    Lager DJ, Burgart LJ, Slagel DD.
    Mod Pathol; 1993 Jan 27; 6(1):42-7. PubMed ID: 8381232
    [Abstract] [Full Text] [Related]

  • 13. Discrimination of Epstein-Barr virus-related posttransplant lymphoproliferations from acute rejection in lung allograft recipients.
    Rosendale B, Yousem SA.
    Arch Pathol Lab Med; 1995 May 27; 119(5):418-23. PubMed ID: 7748068
    [Abstract] [Full Text] [Related]

  • 14. The impact of monitoring Epstein-Barr virus PCR in paediatric bone marrow transplant patients: can it successfully predict outcome and guide intervention?
    Greenfield HM, Gharib MI, Turner AJ, Guiver M, Carr T, Will AM, Wynn RF.
    Pediatr Blood Cancer; 2006 Aug 27; 47(2):200-5. PubMed ID: 16206207
    [Abstract] [Full Text] [Related]

  • 15. Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients.
    Raj R, Frost AE.
    J Heart Lung Transplant; 2005 Jun 27; 24(6):671-9. PubMed ID: 15949726
    [Abstract] [Full Text] [Related]

  • 16. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
    Capello D, Rasi S, Oreste P, Veronese S, Cerri M, Ravelli E, Rossi D, Minola E, Colosimo A, Gambacorta M, Muti G, Morra E, Gaidano G.
    J Pathol; 2009 Aug 27; 218(4):478-86. PubMed ID: 19391128
    [Abstract] [Full Text] [Related]

  • 17. Heart allograft involvement with Epstein-Barr virus-associated posttransplant lymphoproliferative disorder.
    Abu-Farsakh H, Cagle PT, Buffone GJ, Bruner JM, Weilbaecher D, Greenberg SD.
    Arch Pathol Lab Med; 1992 Jan 27; 116(1):93-5. PubMed ID: 1310382
    [Abstract] [Full Text] [Related]

  • 18. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
    Lones MA, Lopez-Terrada D, Shintaku IP, Rosenthal J, Said JW.
    Arch Pathol Lab Med; 1998 Aug 27; 122(8):708-14. PubMed ID: 9701332
    [Abstract] [Full Text] [Related]

  • 19. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
    Srivastava T, Zwick DL, Rothberg PG, Warady BA.
    Pediatr Nephrol; 1999 Nov 27; 13(9):748-54. PubMed ID: 10603113
    [Abstract] [Full Text] [Related]

  • 20. Otolaryngological manifestations of posttransplant lymphoproliferative disorder in pediatric thoracic transplant patients.
    Herrmann BW, Sweet SC, Hayashi RJ, Canter CE, White FV, Lieu JE.
    Int J Pediatr Otorhinolaryngol; 2006 Feb 27; 70(2):303-10. PubMed ID: 16125255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.